-
Published12/04/2016
-
Awarded10/06/2016
-
Deadline10/11/2017
-
Today05/09/2026
Utilities
- indicates text translated automatically in your browsing language
Germany-Düsseldorf: Pharmaceutical products
GWQ ServicePlus AG intends to launch a pan-European open procurement procedure for preparations containing the active substance nevirapin (here Retardform) with the start of the contract on 1 January 2018. For the period up to 31 December 2017, GWQ ServicePlus AG intends to conclude non-exclusive discount agreements under § 130a(8) SGB V on this active substance. Until the start of exclusive contracts, these transitional arrangements are open to all market participants for accession, but for the last time due to the deadlines of 10 November 2017. The contract documents, the participating health insurance funds and their turnover and the dates for notification of the contract are to be consulted and downloaded on the procurement portal of GWQ ServicePlus AG at http://vergabeportal.gwq-serviceplus.de once they have been registered.
Postal address:
Town:
Postal code:
Country: DEU
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.